ask="15.00"
ask_size="300"
average_daily_volume="671934"
bid="10.50"
bid_size="300"
book_value="9.23"
change="-0.27"
change_from_200_day_moving_average="-12.69"
change_from_50_day_moving_average="-1.95"
change_from_52_week_high="-31.62"
change_From_52_week_low="2.78"
change_in_percent="-1.95%"
close="13.58"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.73"
ebitda="-119.41M"
eps_estimate_current_year="-2.82"
eps_estimate_next_quarter="-0.80"
eps_estimate_next_year="-3.28"
ex_dividend_date="N/A"
float_shares="33671000"
high="14.12"
high_52_weeks="45.20"
last_trade_date="1/20/2017"
last_trade_price="13.58"
last_trade_size="21636"
last_trade_time="4:00pm"
low="13.51"
low_52_weeks="10.80"
market_capitalization="587.58M"
moving_average_200_day="26.27"
moving_average_50_day="15.53"
name="Intra-Cellular Therapies Inc."
notes="N/A"
one_year_target_price="35.63"
open="14.00"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-48.30%"
percent_change_from_50_day_moving_average="-12.56%"
percent_change_from_52_week_high="-69.96%"
percent_change_from_52_week_low="+25.74%"
previous_close="13.85"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.50"
price_per_sales="2274.53"
revenue="263466.00"
shares_outstanding="43268000"
short_ratio="6.89"
stock_exchange="NMS"
symbol="ITCI"
volume="398980"
weeks_range_52="10.80 - 45.20"
